BLB develops analysis with highly pure and viable rodent and human primary hepatocytes, liver sinusoidal endothelial cells, hepatic stellate cells and Kupffer cells
Cells are routinely isolated and experiments performed shortly after their separation, allowing proper analysis in non de-differentiated cells. BLB performs analysis in hepatic cells isolated from healthy individuals and, importantly, from livers with cirrhosis (ASH and NASH aetiologies). Primary liver cells can be used to understand the effects of your new chemical compounds on cells phenotype.
Ask us about the wide variety of wide variety of molecular and functional markersthat can be determined.
The complete pre-clinical Solution
EXOLIVER®
BLB offers you the possibility to test your drug candidates in a human liver biological system: the unique and patent-protected ExoLiver platform
BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.
BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, we will assume that you agree to it.AcceptNo
ou can revoke your consent at any time by using the consent revocation button.Revoke consent